4//SEC Filing
D'Onofrio Matthew J 4
Accession 0001209191-20-063098
CIK 0001403708other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 8:41 PM ET
Size
7.0 KB
Accession
0001209191-20-063098
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
D'Onofrio Matthew J
Exec VP, Chief Bus. Officer
Transactions
- Exercise/Conversion
Common Stock
2020-12-09$0.40/sh+46,000$18,400→ 329,997 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-09−46,000→ 0 totalExercise: $0.40Exp: 2021-02-09→ Common Stock (46,000 underlying)
Footnotes (2)
- [F1]These options were scheduled to expire on February 9, 2021.
- [F2]These options were fully vested as of February 9, 2015.
Documents
Issuer
Evoke Pharma Inc
CIK 0001403708
Entity typeother
Related Parties
1- filerCIK 0001578770
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 8:41 PM ET
- Size
- 7.0 KB